Prolonged oxytocin treatment in rats affects intracellular signaling and induces myocardial protection against infarction

General Physiology and Biophysics

Volumn 31, Issue 3, 2012, Pages 261-270

  Ondrejcakova, Maria ^a   Barancik, Miroslav ^b   Bartekova, Monika ^b   Ravingerova, Tana ^b   Jezova, Daniela ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Myocardial infarction; Oxytocin; Protein kinases; Stress

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GELATINASE A; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OXYTOCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; NONHUMAN; RAT;

ANIMALS; CARDIOTONIC AGENTS; CYTOKINES; MALE; MYOCARDIAL INFARCTION; OXYTOCIN; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84867776963     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb-2012-030     Document Type: Article

References (38)

1. Ahmed M. A., Elosaily G. M. (2011): Role of oxytocin in deceleration of early atherosclerotic inflammatory processes in adult male rats. Int. J. Clin. Exp. Med. 4, 169-178
2. Alizadeh A. M., Faghihi M., Sadeghipour H. R., Mohammadghasemi F., Imani A., Houshmand F., Khori V. (2010): Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides 31, 1341-1345 http://dx.doi.org/10.1016/j.peptides. 2010.04.012
3. Bakos J., Bobryshev P., Tillinger A., Kvetnansky R., Jezova D. (2008): Phenylethanolamine N-methyltransferase gene expression in the heart and blood pressure response to oxytocin treatment in rats exposed to voluntary wheel running. Ann. N. Y. Acad. Sci. 1148, 302-307 http://dx.doi.org/10.1196/annals. 1410.031
4. Barancik M., Htun P., Strohm C., Kilian S., Schaper W. (2000): Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J. Cardiovasc. Pharmacol. 35, 474-483 http://dx.doi.org/10.1097/00005344-200003000- 00019 (Pubitemid 30127197)
5. Bradford M. M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 http://dx.doi.org/10.1016/0003-2697 (76) 90527-3
6. Burns P. D., Mendes J. O. Jr., Yemm R. S., Clay C. M., Nelson S. E., Hayes S. H., Silvia W. (2001): Cellular mechanisms by which oxytocin mediates ovine endometrial prostaglandin F2alpha synthesis: role of G (i) proteins and mitogen-activated protein kinases. Biol. Reprod. 65, 1150-1155 http://dx.doi.org/10.1095/biolreprod65.4.1150 (Pubitemid 32927581)
7. Cattaneo M. G., Chini B., Vicentini L. M. (2008): Oxytocin stimulates migration and invasion in human endothelial cells. Br. J. Pharmacol. 153, 728-736 http://dx.doi.org/10.1038/sj.bjp. 0707609 (Pubitemid 351271756)
8. Cattaneo M. G., Lucci G., Vicentini L. M. (2009): Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism. Exp. Cell Res. 315, 3210-3219 http://dx.doi.org/10.1016/j.yexcr.2009.06.022
9. Costa-E-Sousa R. H., Pereira-Junior P. P., Oliveira P. F., Olivares E. L., Werneck-de-Castro J. P., Mello D. B., Nascimento J. H., Campos-de-Carvalho A. C. (2005): Cardiac effectsofoxytocin: is there a role for this peptide in cardiovascular homeostasis? Regul. Pept. 132, 107-112 http://dx.doi.org/10.1016/ j.regpep. 2005.09.011 (Pubitemid 41607509)
10. Devost D., Wrzal P., Zingg H. H. (2008): Oxytocin receptor signalling. Prog. Brain Res. 170, 167-176 http://dx.doi.org/10.1016/S0079-6123 (08) 004 (Pubitemid 352010229)
11. Düsünceli F., Iseri S. O., Ercan F., Gedik N., Yegen C., Yegen B. C. (2008): Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides 29, 1216-1222 http://dx.doi.org/10.1016/j.peptides.2008.02.010
12. Eckertova M., Ondrejcakova M., Krskova K., Zorad S., Jezova D. (2011): Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. Br. J. Pharmacol. 162, 452-463 http://dx.doi.org/10.1111/j.1476- 5381.2010.01037.x
13. Efhymiou C. A., Mocanu M. M., De Belleroche J., Wells D. J., Latchmann D. S., Yellon D. M. (2004): Heat shock protein 27 protects the heart against myocardial infarction. Basic Res. Cardiol. 99, 392-394 http://dx.doi.org/10. 1007/s00395-004-0483-6 (Pubitemid 39462361)
14. Gutkowska J., Jankowski M., Lambert C., Mukaddam-Daher S., Zingg H. H., McCann S. M. (1997) Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc. Natl. Acad. Sci. U. S. A. 94, 11704-11709 http://dx.doi.org/10.1073/pnas.94.21.11704 (Pubitemid 27451062)
15. Gutkowska J., Jankowski M., Mukaddam-Daher S., McCann S. M. (2000): Oxytocin is a cardiovascular hormone. Braz. J. Med. Biol. Res. 33, 625-633 http://dx.doi.org/10.1590/S0100-879X2000000600003
16. Hausenloy D. J., Mocanu M. M., Yellon D. M. (2004): Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc. Res. 63, 305-312 http://dx.doi.org/10.1016/j. cardiores.2004.04.011 (Pubitemid 38900844)
17. Hlavacova N., Jezova D. (2008): Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm. Behav. 54, 90-97 http://dx.doi.org/10.1016/j.yhbeh.2008.02.004
18. Horikawa Y. T., Panneerselvam M., Kawaraguchi Y., Tsutsumi Y. M., Ali S., Balijepalli R. C., Murray F., Head B. P., Niesman I. R., Rieg T., Vallon V., Insel P. A., Patel H. H., Roth D. M. (2011): Cardiac-specific overexpressionof caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling. J. Am. Coll. Cardiol. 57, 2273-2283 http://dx.doi.org/10.1016/j.jacc.2010.12.032
19. Houshmand F., Faghihi M., Zahediasl S. (2009): Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides 30, 2301-2308 http://dx.doi.org/10.1016/j.peptides.2009.09.010
20. Jankowski M., Wang D., Hajjar F., Mukaddam-Daher S., McCann S. M., Gutkowska J. (2000): Oxytocin and its receptors are synthesized in the rat vasculature. Proc. Natl. Acad. Sci. U. S. A. 97, 6207-6211 http://dx.doi.org/10. 1073/pnas.110137497 (Pubitemid 30367548)
21. Jankowski M., Bissonauth V., Gao L., Gangal M., Wang D., Danalache B., Wang Y., Stoyanova E., Cloutier G., Blaise G., Gutkowska J. (2010): Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res. Cardiol. 105, 205-218 http://dx.doi.org/10.1007/s00395-009-0076-5
22. Jezova D., Skultetyova I., Tokarev D. I., Bakos P., Vigas M. (1995): Vasopressin and oxytocin in stress. Ann. N. Y. Acad. Sci. 771, 192-203 http://dx.doi.org/10.1111/j.1749-6632.1995.tb44681.x (Pubitemid 26077407)
23. Kobayashi H., Yasuda S., Bao N., Iwasa M., Kawamura I., Yamada Y., Yamaki T., Sumi S., Ushikoshi H., Nishigaki K., Takemura G., Fujiwara T., Fujiwara H., Minatoguchi S. (2009): Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J. Cardiovasc. Pharmacol. 54, 510-509 http://dx.doi.org/10.1097/FJC. 0b013e3181bfac02
24. MacIntyre D. A., Tyson E. K., Read M., Smith R., Yeo G., Kwek K., Chan E. C. (2008): Contraction in human myometrium is associated with changes in small heat shock proteins. Endocrinology 149, 245-252 http://dx.doi.org/10.1210/en. 2007-0662
25. Miyamoto S., Murphy A. N., Brown J. H. (2009): Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J. Bioenerg. Biomembr. 41, 169-180 http://dx.doi.org/10.1007/s10863-009-9205-y
26. Mocanu M. M., Baxter G. F., Yue Y., Critz S. D., Yellon D. M. (2000): The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical. Basic Res. Cardiol. 95, 472-478 http://dx.doi.org/10.1007/s003950070023 (Pubitemid 32013987)
27. Moghimian M., Faghihi M., Karimian S. M., Imani A. (2011): The effect of acute stress exposure on ischemia and reperfusion injury in rat heart: role of oxytocin. Stress (in press) http://dx.doi.org/10.3109/10253890.2011.630436
28. Ondrejcakova M., Ravingerova T., Bakos J., Pancza D., Jezova D. (2009): Oxytocin exerts protective effects onin vitro myocardial injury induced by ischemia and reperfusion. Can J. Physiol. Pharmacol. 87, 137-142 http://dx.doi.org/10.1139/Y08-108
29. Ondrejcakova M., Bakos J., Garafova A., Kovacs L., Kvetnansky R., Jezova D. (2010): Neuroendocrine and cardiovascular parameters during simulation of stress-induced rise in circulating oxytocin in the rat. Stress 13, 314-322 http://dx.doi.org/10.3109/10253891003596822
30. Ravingerova T., Barancik M., Strniskova M. (2003): Mitogenactivated protein kinases: a new therapeutic target in cardiac pathology. Mol. Cell. Biochem. 247, 127-138 http://dx.doi.org/10.1023/A:1024119224033 (Pubitemid 36798517)
31. Ravingerova T., Matejikova J., Neckar J., Andelova E., Kolar F. (2007): Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart. Mol. Cell. Biochem. 297, 111-120 http://dx.doi.org/10.1007/s11010-006-9335-z (Pubitemid 46443535)
32. Schönbeck U., Mach F., Sukhova G. K., Murphy C., Bonnefoy J. Y., Fabunmi R. P., Libby P. (1997): Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ. Res. 81, 448-454 http://dx.doi.org/10. 1161/01. RES.81.3.448 (Pubitemid 27362532)
33. Simoncikova P., Ravingerova T., Barancik M. (2008): The effect of chronic doxorubicin treatment on mitogen-activated protein kinases and heat stress proteins in rat hearts. Physiol. Res. 57, S97-102
34. Spanikova A., Ivanova M., Matejikova J., Ravingerova T., Barancik M. (2010): Influence of ischemia/reperfusion and modulation of PI3K/Akt kinase pathway on matrix metalloproteinase-2 in rat hearts. Gen. Physiol. Biophys. 29, 31-40 http://dx.doi.org/10.4149/gpb-2010-01-31
35. Strniskova M., Ravingerova T., Neckar J., Kolar F., Pastorekova S., Barancik M. (2006): Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. Gen. Physiol. Biophys. 25, 25-41 (Pubitemid 43797128)
36. Thibonnier M., Conarty D. M., Preston J. A., Plesnicher C. L., Dweik R. A., Erzurum S. C. (1999): Human vascular endothelial cells express oxytocin receptors. Endocrinology 140, 1301-1309 http://dx.doi.org/10.1210/en. 140.3.1301 (Pubitemid 29104234)
37. Tugtepe H., Sener G., Biyikli N. K., Yüksel M., Cetinel S., Gedik N., Yegen B. C. (2007): The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regul. Pept. 140, 101-108 http://dx.doi.org/10.1016/j.regpep. 2006.11.026 (Pubitemid 46418907)
38. Yue Y., Qin Q., Cohen M. V., Downey J. M., Critz S. D. (2002): The relative order of mK (ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc. Res. 55, 681-689 http://dx.doi.org/10.1016/S0008-6363 (02) 00452-2 (Pubitemid 34874960)